Interventional Cardiology

This cardiac subspecialty uses minimally invasive, catheter-based technologies in a cath lab to diagnose and treat coronary artery disease (CAD). The main focus in on percutaneous coronary interventions (PCI) to revascularize patients with CAD that is causing blockages resulting in ischemia or myocardial infarction. PCI mainly consists of angioplasty and implanting stents. Interventional cardiology has greatly expanded in scope over recent years to include a number of transcatheter structural heart interventions.

RSS icon
Sahil Parikh explains the tread of cardiology departments treating critical limb ischemia (CLI) at AHA 2022.

Interventional cardiology's role in treating CLI continues to evolve

Sahil Parikh, MD, talked to Cardiovascular Business about growing trends related to the treatment of critical lower limb ischemia. "We are getting better and better at saving their limbs, but we are not better at saving their lives," he said. 

Sahil A. Parikh, MD, Director of Endovascular Services at Columbia University Irving Medical Center and Associate Professor of Medicine at the Columbia University College of Physicians and Surgeons, explained the growing trend or interventional cardiologists treating PAD and CLI. He shares what he thinks is important for cardiology departments to know before expanding expanding their programs in this space.

What do interventional cardiologists need to treat PAD and CLI?

Sahil Parikh, MD, director of endovascular services at Columbia University Irving Medical Center, said treating these patients can be quite challenging. 

Tim Attebery, DSc, MBA, the CEO of Cardiovascular Associates of America and former CEO of the American College of Cardiology (ACC)

Q&A: Tim Attebery on why private equity-backed management companies are investing in cardiology

The CEO of Cardiovascular Associates of America, and former CEO of the American College of Cardiology, shared his perspective on the rise of private equity investments in cardiology. 

private equity cardiology healthcare

Q&A: What the rise of private equity investments in cardiology means for cardiologists and their patients

Private equity investors have grown more and more interested in cardiology in recent years. Why the sudden shift? And what does it mean for patient care going forward? 

Thumbnail

A busy week for cardiology investments: 3 tech companies report big financing rounds

It’s not even Valentine’s Day yet, but February has already been a big month for fundraising in the cardiology space.

Cardiologist the subject of several malpractice claims for allegedly performing unnecessary heart operations

One patient received a total of 41 stents from 2004 to 2013. He said the experience was so hard that he feared he would be driven to suicide. 

CorPath GRX System siemens

Corindus, acquired back in 2019, is now Siemens Healthineers Endovascular Robotics

The company's most well-known product within the industry is the CorPath GRX System, a second-generation robotics solution used by interventional cardiologists during PCI and other interventional procedures.

Interventional cardiology to join the Match in 2025

It is an announcement many interventional cardiologists have been waiting to hear for a long time. 

Displaying 49 - 56 of 79

Around the web

Cardiovascular Business
Q&A: MedAxiom CEO explores key trends in cardiologist, cardiovascular surgeon compensation

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

Cardiovascular Business
Payment cuts and beyond: Key takeaways for cardiologists from the 2025 Medicare Physician Fee Schedule

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

AI in Healthcare
A modest proposal to rally AI regulators around a simple game plan

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”